|
1
|
Brown RL, de Souza JA and Cohen EE:
Thyroid cancer: burden of illness and management of disease. J
Cancer. 2:193–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thompson L: World Health Organization
classification of tumours: pathology and genetics of head and neck
tumours. Ear Nose Throat J. 85:742006.PubMed/NCBI
|
|
3
|
Nikiforova MN and Nikiforov YE: Molecular
genetics of thyroid cancer: implications for diagnosis, treatment
and prognosis. Expert Rev Mol Diagn. 8:83–95. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dal Maso L, Bosetti C, La Vecchia C and
Franceschi S: Risk factors for thyroid cancer: an epidemiological
review focused on nutritional factors. Cancer Causes Control.
20:75–86. 2009.PubMed/NCBI
|
|
5
|
Jeong SY, Kim HW, Lee SW, Ahn BC and Lee
J: Salivary gland function 5 years after radioactive iodine
ablation in patients with differentiated thyroid cancer: direct
comparison of pre- and postablation scintigraphies and their
relation to xerostomia symptoms. Thyroid. 23:609–616. 2013.
|
|
6
|
Matuszczyk A, Petersenn S, Bockisch A, et
al: Chemotherapy with doxorubicin in progressive medullary and
thyroid carcinoma of the follicular epithelium. Horm Metab Res.
40:210–213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Strasser JF, Raben A and Koprowski C: The
role of radiation therapy in the management of thyroid cancer. Surg
Oncol Clin N Am. 17:219–232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Ni J, Zhou G, et al: Cloning,
expression and characterization of the human NOB1 gene. Mol Biol
Rep. 32:185–189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Makarova KS, Aravind L and Galperin MY:
Comparative genomics of the Archaea (Euryarchaeota): evolution of
conserved protein families, the stable core, and the variable
shell. Genome Res. 9:608–628. 1999.PubMed/NCBI
|
|
10
|
Arcus VL, Backbro K, Roos A, Daniel EL and
Baker EN: Distant structural homology leads to the functional
characterization of an archaeal PIN domain as an exonuclease. J
Biol Chem. 279:16471–16478. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lamanna AC and Karbstein K: Nob1 binds the
signal-stranded cleavege site D at the 3′-end of 18S rRNA with its
PIN domain. Proc Natl Acad Sci USA. 106:14259–14264.
2009.PubMed/NCBI
|
|
12
|
Fatica A, Tollervey D and Dlakic M: PIN
domain of Nob1p is required for D-site cleavage in 20S pre-rRNA.
RNA. 10:1698–1701. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fatica A, Oeffinger M, Dlakic M and
Tollervey D: Nob1p is required for cleavage of the 3′ end of 18S
rRNA. Mol Cell Biol. 23:1798–1807. 2003.
|
|
14
|
Veith T, Martin R, Wurm JP, et al:
Structural and functional analysis of the archaeal endonuclease
Nob1. Nucleic Acids Res. 40:3259–3274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nazar RN: Ribosomal RNA processing and
ribosome biogenesis in eukaryotes. IUBMB Life. 56:457–465. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Montanaro L, Trere D and Derenzini M:
Changes in ribosome biogenesis may induce cancer by down-regulating
the cell tumor suppressor potential. Biochim Biophys Acta.
1825:101–110. 2012.PubMed/NCBI
|
|
17
|
Hershko A and Ciechanover A: The ubiquitin
system. Annu Rev Biochem. 67:425–479. 1998. View Article : Google Scholar
|
|
18
|
Ferrell K, Wilkinson CR, Dubiel W and
Gordon C: Regulatory subunit interactions of the 26S proteasome, a
complex problem. Trends Biochem Sci. 25:83–88. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Micel LN, Tentler JJ, Smith PG and
Eckhardt GS: Role of ubiquitin ligases and the proteasome in
oncogenesis: novel targets for anticancer therapies. J Clin Oncol.
31:1231–1238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mani A and Gelmann EP: The
ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol.
23:4776–4789. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin Y, Peng S, Yu H, Teng H and Cui M:
RNAi-mediated down-regulation of NOB1 suppresses the growth and
colony-formation ability of human ovarian cancer cells. Med Oncol.
29:311–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Che JP, Li W, Yan Y, et al: Expression and
clinical significance of the nin one binding protein and p38 MAPK
in prostate carcinoma. Int J Clin Exp Pathol. 6:2300–2311.
2013.PubMed/NCBI
|
|
23
|
Li XY, Luo QF, Li J, et al: Clinical
significance of NOB1 expression in breast infiltrating ductal
carcinoma. Int J Clin Exp Pathol. 6:2137–2144. 2013.PubMed/NCBI
|
|
24
|
Li Y, Ma C, Qian M, Wen Z, Jing H and Qian
D: Downregulation of NOB1 suppresses the proliferation and tumor
growth of non-small cell lung cancer in vitro and in
vivo. Oncol Rep. 31:1271–1276. 2014.PubMed/NCBI
|
|
25
|
Lin S, Meng W, Zhang W, et al: Expression
of the NOB1 gene and its clinical significance in papillary thyroid
carcinoma. J Int Med Res. 41:568–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang WY, Chen DH and Ning L: siRNA
mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits
proliferation and growth of breast cancer cells. Asian Pac J Cancer
Prev. 13:1823–1827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu Z, Guo Q, Shi A, Xie F and Lu Q: Down
regulation of NIN/RPN12 binding protein inhibits the growth of
human hepatocellular carcinoma cells. Mol Biol Rep. 39:501–507.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guoan X, Hanning W, Kaiyun C and Hao L:
Adenovirus-mediated siRNA targeting Mcl-1 gene increases
radiosensitivity of pancreatic carcinoma cells in vitro and in
vivo. Surgery. 147:553–561. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J, Sun M, Zhang A, Lv C, De W and
Wang Z: Adenovirus-mediated siRNA targeting Bcl-xL inhibits
proliferation, reduces invasion and enhances radiosensitivity of
human colorectal cancer cells. World J Surg Oncol. 9:1172011.
View Article : Google Scholar
|
|
30
|
Lin CI, Whang EE, Donner DB, et al:
Galectin-3 targeted therapy with a small molecule inhibitor
activates apoptosis and enhances both chemosensitivity and
radiosensitivity in papillary thyroid cancer. Mol Cancer Res.
7:1655–1662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tone Y, Tanahashi N, Tanaka K, Fujimuro M,
Yokosawa H and Toh-e A: Nob1p, a new essential protein, associates
with the 26S proteasome of growing saccharomyces cerevisiae cells.
Gene. 243:37–45. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu G, Bernaudo S, Fu G, Lee DY, Yang BB
and Peng C: Cyclin G2 is degraded through the ubiquitin-proteasome
pathway and mediates the antiproliferative effect of activin
receptor-like kinase 7. Mol Biol Cell. 19:4968–4979. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fasanaro P, Capogrossi MC and Martelli F:
Regulation of the endothelial cell cycle by the
ubiquitin-proteasome system. Cardiovasc Res. 85:272–280. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang H, Li P and Zhao B: Knockdown of NOB1
expression by RNAi inhibits cellular proliferation and migration in
human gliomas. Gene. 528:146–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yacoub A, Mitchell C, Lebedeva IV, et al:
mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of
glioma cells in vitro via JNK signaling. Cancer Biol Ther.
2:347–353. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sofia Vala I, Martins LR, Imaizumi N, et
al: Low doses of ionizing radiation promote tumor growth and
metastasis by enhancing angiogenesis. PLoS One.
5:e112222010.PubMed/NCBI
|
|
39
|
Zhou J, Xu T, Yan Y, et al: MicroRNA-326
functions as a tumor suppressor in glioma by targeting the Nin one
binding protein (NOB1). PLoS One. 8:e684692013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View Article : Google Scholar : PubMed/NCBI
|
